Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib Meeting Abstract
| Authors: | Brown, J. R.; Zelenetz, A. D.; Furman, R. R.; Lamanna, N.; Mato, A. R.; Montillo, M.; O'Brien, S. M.; Dreiling, L. K.; Dubowy, R. L.; Kim, Y.; Munugalavada, V. B.; Robak, T.; Hillmen, P. |
| Abstract Title: | Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419700216 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.3016.3016 |
| Notes: | Meeting Abstract: 3016 -- Source: Wos |
